On ECHEMI
Home > Drugs > leukemia
leukemia
Leukemia was first identified by German pathologist Rudolf Virchow in 1847. The cause of leukemia is the abnormal functioning of the hematopoietic tissue in the bone marrow due to mutations in the DNA in the cells. Stem cells in the bone marrow can produce thousands of red and white blood cells every day. Leukemia patients overproduce immature white blood cells, which interferes with other work of the bone marrow, which reduces the bone marrow's ability to produce other blood cells. Leukemia can spread to the lymph nodes, spleen, liver, central nervous system and other organs.
Related Drugs
Thioguanine Tablets
Indication: 1. The induction remission phase and continued treatment phase of acute lymphocytic leukemia and acute non-lymphocytic leukemia. 2. The chronic phase and blast phase of chronic myeloid leukemia.
Thioguanine Tablets
Indication: 1. The induction remission phase and continued treatment phase of acute lymphocytic leukemia and acute non-lymphocytic leukemia. 2. The chronic phase and blast phase of chronic myeloid leukemia.
Thioguanine Tablets
Indication: 1. The induction remission period and continuing treatment period of acute lymphocytic leukemia and acute non-lymphocytic leukemia; 2. The chronic phase and blast crisis phase of chronic myeloid leukemia.
Manufacturer:

Beijing Jialin Pharmaceutical Co., Ltd.

Azathioprine Tablets
Indication: 1. Acute and chronic leukemia, with good short-term efficacy for chronic myeloid leukemia, rapid effect, but short remission period; 2. Acquired hemolytic anemia, idiopathic thrombocytopenic purpura, systemic lupus erythematosus; 3. Chronic rheumatoid arthritis, chronic active hepatitis (hepatitis related to autoimmunity), primary biliary cirrhosis; 4. Hyperthyroidism, myasthenia gravis; 5. Others: chronic nonspecific ulcerative colitis, segmental enteritis, polyradiculitis, lupus nephritis, proliferative nephritis, Wegener's granulomatosis, etc.
Manufacturer:

Shanghai Sine Pharmaceutical Laboratories Co., Ltd.

Azathioprine Tablets
Indication: 1. Acute and chronic leukemia. It has a better short-term effect on chronic myeloid leukemia and works quickly, but the remission period is short. 2. Acquired hemolytic anemia, idiopathic thrombocytopenic purpura, systemic lupus erythematosus. 3. Chronic rheumatoid arthritis, chronic active hepatitis (hepatitis related to autoimmunity), primary biliary cirrhosis. 4. Hyperthyroidism, myasthenia gravis. 5. Others: chronic nonspecific ulcerative colitis, segmental enteritis, polyradiculitis, lupus nephritis, proliferative nephritis, Wegener's granulomatosis, etc.
Manufacturer:

Shanghai Sine Pharmaceutical Laboratories Co., Ltd.

Azathioprine Tablets
Indication: 1. Acute and chronic leukemia, with good short-term efficacy for chronic myeloid leukemia, rapid effect, but short remission period; 2. Acquired hemolytic anemia, idiopathic thrombocytopenic purpura, systemic lupus erythematosus; 3. Chronic rheumatoid arthritis, chronic active hepatitis (hepatitis related to autoimmunity), primary biliary cirrhosis; 4. Hyperthyroidism, myasthenia gravis; 5. Others: chronic nonspecific ulcerative colitis, segmental enteritis, polyradiculitis, lupus nephritis, proliferative nephritis, Wegener's granulomatosis, etc.
Mercaptopurine Tablets
Indication: It is suitable for choriocarcinoma, malignant hydatidiform mole, acute lymphocytic leukemia, acute non-lymphocytic leukemia, and the blast crisis of chronic myeloid leukemia.
Manufacturer:

Shanghai Sine Pharmaceutical Laboratories Co., Ltd.

Mercaptopurine Tablets
Indication: It is suitable for choriocarcinoma, malignant hydatidiform mole, acute lymphocytic leukemia, acute non-lymphocytic leukemia, and the blast crisis of chronic myeloid leukemia.
Manufacturer:

Shanghai Sine Pharmaceutical Laboratories Co., Ltd.

Mercaptopurine Tablets
Indication: It is suitable for choriocarcinoma, malignant hydatidiform mole, acute lymphocytic leukemia, acute non-lymphocytic leukemia, and the blast crisis of chronic myeloid leukemia.
Manufacturer:

Shanghai Sine Pharmaceutical Laboratories Co., Ltd.

Mercaptopurine Tablets
Indication: It is suitable for choriocarcinoma, malignant hydatidiform mole, acute lymphocytic leukemia, acute non-lymphocytic leukemia, and the blast crisis of chronic myeloid leukemia.
Manufacturer:

Shanghai Sine Pharmaceutical Laboratories Co., Ltd.

Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.